Published: 19-12-2022
Review
Chylothorax associated with sarcoidosis: a review of the literature
Abstract 464 | PDF Downloads 385Page e2022039
Original Articles: Clinical Research
Serum Krebs von den Lungen-6: promising biomarker to differentiate CPFE from IPF
Abstract 559 | PDF Downloads 480Page e2022035
Infliximab decreases inflammatory activity but has no effect on small fiber neuropathy related symptoms in Dutch patients with sarcoidosis
Abstract 494 | PDF Downloads 162Page e2022033
Intravenous immunoglobulin for acute exacerbation of fibrotic idiopathic interstitial pneumonias
Abstract 792 | PDF Downloads 631Page e2022038
Role of computed tomography findings, complete blood count parameters and systemic inflammatory markers for predicting the severity in interstitial lung diseases
Abstract 627 | PDF Downloads 388Page e2022042
Original Articles: Laboratory Research
Metagenomic sequencing of the bronchoalveolar lavage extracellular virome and cellular transcriptome of sarcoidosis patients does not detect rubella virus
Abstract 487 | PDF Downloads 428Page e2022040
Case Reports
A case of hepatic and bone marrow sarcoidosis with progressive renal failure: diagnostic and therapeutic challenges
Abstract 412 | PDF Downloads 377Page e2022041
Letter to Editor
Management of high-degree atrioventricular block in the setting of cardiac sarcoidosis: A therapeutic controversy
Abstract 388 | PDF Downloads 331Page e2022036
Comment on: Atherogenic indices can predict atherosclerosis in patients with sarcoidosis
Abstract 327 | PDF Downloads 310Page e2022037